|Articles|November 15, 2016
- Pharmaceutical Technology-11-15-2016
- Volume 2016 eBook
- Issue 3
Microbiological Testing: Time is of the Essence
Author(s)Cynthia A. Challener
Pressures to accelerate current and next-gen therapies are challenging traditional microbiological testing models.
Advertisement
Effective microbiological testing during biopharmaceutical drug development and manufacturing is crucial for ensuring sterility, determining antimicrobial effectiveness, detecting microbial contamination or bioburden levels, analyzing endotoxins, and implementing environmental monitoring programs.
Growing pressures to increase productivity, flexibility, and cost-effectiveness and the unique properties of many next-generation therapies are challenging today’s microbiologists.
Download Pharmaceutical Technology’s
.
Articles in this issue
about 9 years ago
Extending QMS to Contract Partnersabout 9 years ago
Investigation Effectiveness Drives Human Performance Excellenceabout 9 years ago
Is Global Regulatory Gridlock Slowing Modernization?about 9 years ago
Paperless Batch Records for the Massesabout 9 years ago
Ensuring Quality in Pharmaceutical Raw MaterialsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
2
At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development
3
PharmTech Weekly News Roundup — Week of November 10, 2025
4
